Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
Tiago Silva, Marie‐Louise F. van Velthuysen, Casper H.J. van Eijck, et al.
Endocrinology Diabetes and Metabolism Case Reports (2018) Vol. 2018
Open Access | Times Cited: 17

Showing 17 citing articles:

The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors
James R. Howe, Nipun B. Merchant, Claudius Conrad, et al.
Pancreas (2019) Vol. 49, Iss. 1, pp. 1-33
Open Access | Times Cited: 309
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
Anna Kathrin Stueven, Antonin Kayser, Christoph Wetz, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3049-3049
Open Access | Times Cited: 171
Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges
Suliman Salih, Ajnas Alkatheeri, Wijdan Alomaim, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5231-5231
Open Access | Times Cited: 53
Neuroendocrine Tumor Therapy with Lutetium-177: A Literature Review
Muhammad Haisum Maqsood, Asim Tameez Ud Din, Ameer Khan
Cureus (2019)
Open Access | Times Cited: 34
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
Andrea Lania, Francesco Ferraù, Manila Rubino, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 20
Role of neoadjuvant peptide receptor radionuclide therapy in unresectable and metastatic gastro‐entero‐pancreatic neuroendocrine neoplasms: A scoping review
Raghava Kashyap, Senthil Raja, Ajay Adusumilli, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 2
Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
Vera G. Megdanova-Chipeva, Ángela Lamarca, Alison Backen, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1988-1988
Open Access | Times Cited: 18
Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
Marta Opalińska, Anna Sowa‐Staszczak, Aneta Grochowska, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review
Luca Urso, Alberto Nieri, Ilaria Rambaldi, et al.
Endocrine (2022) Vol. 78, Iss. 2, pp. 255-261
Open Access | Times Cited: 8
Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study
Charlotte M. Heidsma, Diamantis I. Tsilimigras, Flavio G. Rocha, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2242-2242
Open Access | Times Cited: 9
Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model
Marina Simón, Jesper Tranekjær Jørgensen, Harshvardhan A. Khare, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1284-1284
Open Access | Times Cited: 6
Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy
Jaume Capdevila, Enrique Grande, Rocio García‐Carbonero, et al.
The Oncologist (2022) Vol. 27, Iss. 4, pp. e328-e339
Open Access | Times Cited: 5
Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies
Tanaz Vaghaiwalla, Brian Ruhle, Kelvin Memeh, et al.
Surgery (2020) Vol. 169, Iss. 1, pp. 162-167
Closed Access | Times Cited: 6
Neoadjuvant PRRT for advanced pNEN: an unusual highlander
Isabella Zanata, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Endocrine (2021) Vol. 73, Iss. 2, pp. 493-495
Open Access | Times Cited: 3
Surgical strategy for neuroendocrine liver metastases
A. Fung, Charing C. N. Chong
Surgical Practice (2019) Vol. 23, Iss. 2, pp. 59-67
Closed Access | Times Cited: 1
Symptomatic and radiological response to 177-Lu-DOTATE treatment of a neuroendocrine tumor of the rectum with liver metastasis: Case report
Mariana Ferrari de Jesus Abdalla, Giselle Cristina dos Santos almeida, Hézio Jadir Fernandes
Medical Case reports and Reviews (2020) Vol. 3, Iss. 1
Open Access
Combined medical therapy, nuclear medicine therapy and other therapies in metastatic neuroendocrine tumor
Isabel Nagel, Ken Herrmann, Harald Lahner, et al.
Elsevier eBooks (2022), pp. 145-156
Closed Access
Page 1

Scroll to top